[ Skip to Main Content ]
COVID-19: How We’re Responding

Our Work

This week, our staff took part in the 2021 @TzHealthSummit including keynote speaker @MasakoPrudence, presenters Dr. Moke Magoma & Deus Ngerangera & Youth Capacity Building facilitator @RehemaGeorge7. Congratulations team! #THS2021 #Tanzania

Meet the 2021 3rd @TzHealthSummit Youth Capacity Building Program facilitators: @RehemaGeorge7 and @MasakoPrudence (@EngenderHealth); @Theddylp (@HealiTZambia), and yours truly (@Jhpiego). Pls show some ❤️ to these selfless #leaders I was blessed to work alongside🙏🏽

Honored to have facilitated the 3rd @TzHealthSummit youth capacity building program alongside @Theddylp @charleswanga. Proud to have been part of nurturing other youth leaders to take up space in the world and cement themselves #THS2021 @EngenderHealth @YouthDeliver

J'ai eu l'honneur d'aborder la thématique des violences domestiques en #CIV225 avec @Sylvia_Apata sur les ondes de Radio Yopougon et notamment le projet de lois relatif à la protection des victimes de violences domestiques.
#ProjetLoiVBG
#TousUnis

@EngenderHealth @CACi225

"This has become an ideological issue. As countries become more partisan, as countries become more ideological on each side, women's bodies are used as a pawn in this war between two parties or three parties."
#SRHR #ReproductiveRights

http://ow.ly/es7Q50Gr5Wr

"...[CSE programs]reinforce our human rights to autonomy, teach youth that sexual violence is not ok & provide young people with information about how to recognize and respond to sexual violence if it were to happen in the future." 💯 🙌 👏
http://ow.ly/Qlsh50Gqptk

Today, 400,000 Nigerian women—representing 40% of obstetric #fistula cases worldwide—wait for corrective surgery. In #Nigeria, MOMENTUM Safe Surgery is partnering w/ gov't, institutions, and local organizations to confront this preventable problem. @USAIDNigeria @PaulineKTallen

Salma advocates to end stigma & discrimination against people living w/ HIV in #Tanzania. She uses skills learned through the Boresha Afya project funded by @USAIDTanzania & administered by @EGPAF in partnership with EngenderHealth & the Tanzania Ministry of Health. #DayoftheGirl

In response to #Pandemics we need Public Private partnerships in cofinancing the health sector so that no one is left behind.

Dr. @MasakoPrudence from @EngenderHealth
#THS2021

Today in the US is #IndigenousPeoplesDay, which celebrates the contributions, diverse cultures, and resiliency of Indigenous people. Learn more about the holiday & what it means to 5 Indigenous women and two-spirit people.

http://ow.ly/Skan50GoTxb

Load More...

Eclampsia and Pre-Eclampsia

Giving birth should be a time for celebration, but for more than half a million women each year—one every 90 seconds—pregnancy and childbirth end in death and mourning. Ninety-nine percent of these deaths occur in developing countries, and nearly all are preventable.

One of the leading causes of maternal death is pre-eclampsia—the rapid elevation of blood pressure during pregnancy—which, if untreated, can lead to seizures (eclampsia), kidney and liver damage, and ultimately, death. Eclampsia and severe pre-eclampsia claim the lives of an estimated 63,000 women each year, as well as the lives of many of their babies.  

A Ready Solution
The World Health Organization recognizes and recommends injectable magnesium sulfate—also known as Epsom salts—as the safest, most effective, and lowest-cost medication for treating pre-eclampsia and eclampsia. Magnesium sulfate is the standard treatment for these conditions in the developed world and has been for 20 years. Less-effective and riskier medications (such as diazepam and phenytoin), however, are still widely used in developing countries—if any treatment is available at all.

 

OUR COMMITMENT
We commit to reducing maternal mortality with magnesium sulfate in India, Mexico, and Nigeria. Through training, advocacy, and education, we will increase access to the lifesaving treatment for pre-eclampsia and eclampsia, leading causes of maternal mortality.

 

 

Clinton Global Initiative Commitment
This disparity must end. EngenderHealth, the University of Oxford, and the John D. & Catherine T. MacArthur Foundation are making a joint commitment as part of the Clinton Global Initiative to expand access to magnesium sulfate by:

  • Training health professionals through web-based interactive programs on when and how to administer magnesium sulfate
  • Advocating for magnesium sulfate to be part of every developing country’s list of essential drugs
  • Helping develop and/or reinforce national protocols mandating magnesium sulfate as the preferred treatment for pre-eclampsia and eclampsia
  • Ensuring the availability of magnesium sulfate in hospitals

Call to Action
In 2007, EngenderHealth and the University of Oxford brought together leading scientists, advocates, researchers, and representatives of the WHO, UNICEF, United Nations agencies, and national ministries of health from around the world to identify barriers to the availability and use of magnesium sulfate to treat pre-eclampsia and eclampsia. This historic gathering of global public health experts identified the primary barriers to be a lack of national guidelines, a shortage of educated and trained health care professionals, and scarce supplies of magnesium sulfate.

Based on these conclusions, EngenderHealth and the University of Oxford developed a “Call to Action” and report that called on policy makers and ministers of health to make pre-eclampsia and eclampsia a higher priority and to set national guidelines for treatment and care based on WHO guidelines. Decision makers and international and national health organizations and agencies were also urged to help make magnesium sulfate more available and affordable.

The full report, Balancing the Scales: Expanding Treatment for Pregnant Women with Life-Threatening Hypertensive Conditions in Developing Countries, is available for download (PDF, 316KB), as is the International Call to Action (PDF, 27KB).

Share this page: